Biomath Models builds production software that transforms HTA submissions, regulatory dossiers, and market access strategies into scalable digital assets. We develop web applications and APIs that integrate clinical epidemiology, health economics, evidence synthesis, and machine learning to support product lifecycle decisions from early development through post-market surveillance. Our unified product team, combining software engineers and quantitative scientists, delivers audit-ready solutions: budget impact and cost-effectiveness modeling platforms, living systematic review and network meta-analysis pipelines, real-world evidence generation systems, and interactive value demonstration tools. By automating complex methodologies within validated computational frameworks, we help pharma and medtech companies accelerate evidence generation, streamline regulatory submissions, and demonstrate product value to payers and HTA bodies worldwide.
